INVESTOR FACT SHEET | Q2 2023
Stock Symbol: CSE: AAWH.U | OTCQX: AAWH | Investor | Rebecca Koar | (617) 453-4042 ext. 90102 |
Diluted Shares Outstanding: 219M* Stock Price: $0.62* Market Cap: $136M* | Contact | SVP, Investor Relations ir@awholdings.com |
* Fully Diluted Shares Outstanding and Stock Price as of 6/30/23
BUSINESS OVERVIEW
AWH is a vertically integrated operator with assets in Illinois, Michigan, Massachusetts, Ohio, New Jersey, Pennsylvania, and Maryland. AWH owns and operates state-of-the-art cultivation facilities, grows award- winning strains, and produces a curated selection of products. AWH produces and distributes its Simply Herb, Ozone and Ozone Reserve branded products.
For more information, visit www.awholdings.com.
SELECT FLAGSHIP LOCATIONS:
RECENT ANNOUNCEMENTS:
- Announces Leadership Transition
- Launches Adult Use at Four Dispensaries in Maryland
- Closed on Acquisition to Acquire Four Maryland Dispensaries
- Opens 1st Outlet Store in Illinois
- Opens New Outlet Dispensary in Michigan
- Announces Q1 and FY 2022 Financial Results
- Opens 3rd Dispensary in Massachusetts
- Opens 2nd Dispensary in Pennsylvania
S T . L O U I S | C H I C A G O | C H I C A G O | B O S T O N | N E W J E R S E Y | N E W J E R S E Y 1 |
A R E A |
COLLINSVILLE | RIVER | LOGAN | BOSTON |
NORTH | SQUARE | GARDEN / | |
FANEUIL HALL | |||
S t r a t e g i c a l l y | L o c a t e d j u s t | L o c a t e d n e a r | D o w n t o w n |
l o c a t e d i n t h e | o u t s i d e | P a l m e r a n d | B o s t o n l o c a t e d |
r e t a i l c o r r i d o r | C h i c a g o | L o g a n s q u a r e | b e t w e e n T D |
n e a r S t . L o u i s | L o o p , t h e | s t e p s t o t h e | G a r d e n a n d |
c e n t r a l | t r a i n | F a n e u i l H a l l | |
s h o p p i n g a n d | |||
b u s i n e s s | |||
d i s t r i c t |
7 states, 31 operating dispensaries
ILLINOIS | NEW JERSEY | MICHIGAN |
9 retail | 3 retail | 8 retail |
1 pending retail2 | 1 cultivation / processing | 1 cultivation / processing |
1 cultivation / processing | ||
MASSACHUSETTS | OHIO | PENNSYLVANIA |
3 retail | 2 medical retail | 2 retail |
1 cultivation / processing | 3 pending medical retail2 | 4 planned medical retail licenses1 |
1 cultivation / processing | 1 cultivation / processing | |
MARYLAND | ||
4 retail
- License is owned by AWH, but the site is not yet operational and/or under construction. Includes 4 Pennsylvania dispensaries.
- Includes pending acquisition of Ohio Patient Access LLC (3 OH dispensaries under construction) and/or InLabs IL dispensary.
PARAMUS | FORT LEE |
AREA | |
O n R t . 1 7 a n d | M i n u t e s t o t h e |
a m i l e f r o m | G e o r g e |
G a r d e n S t a t e | W a s h i n g t o n |
P l a z a i n | B r i d g e , N J |
N o r t h e r n N J | T u r n p i k e , a n d |
N J R t . 4 6 |
IL | MA |
NJ
MIMD
PA
OH
Current Operations
2020 YE
12 Dispensaries
74,000 ft2 Canopy
2021 YE | CURRENT | PIPELINE |
20 Dispensaries | 31 Operating Dispensaries | 39 Operating Dispensaries(1,2) |
175,000 ft2 Canopy | 8 Additional Owned Dispensary | |
Licenses(1,2) | ||
245,000 ft2 Canopy |
FINANCIAL HIGHLIGHTS
$ in U.S. millions, unless otherwise noted
Net Revenue | Adjusted GM% | Adjusted EBITDA | |
$123.0 | |||
$114.2 | |||
$97.5 | 45.6% | $20.9 | $23.3 |
41.7% | $21.3 | ||
36.5% |
Adj. | |||||||||||
21.4% | 20.4% | 17.3% EBITDA | |||||||||
Margin | |||||||||||
2Q22 | 1Q23 | 2Q23 | |||||||||
2Q22 | 1Q23 | 2Q23 | 2Q22 | 1Q23 | 4Q22 | ||||||
Full Year 2022 Revenue | 2Q23 Net Revenue Split |
$405.9 | ||
Wholesale, net | Retail | |
$332.4 | ||
27% | ||
73% | ||
2021 | 2022 |
MANAGEMENT TEAM* | BOARD OF DIRECTORS* |
John Hartmann, Chief Executive Officer | Abner Kurtin, Executive Chairman |
Dan Neville, Chief Financial Officer | Frank Perullo, Director |
David Gacom, Chief Commercial Officer | Scott Swid, Independent Director |
Robin Debiase, Chief People Officer | Josh Gold, Independent Director |
Brian Miesieski, Chief Marketing Officer | Sam Brill, Independent Director |
*Effective 5/15/23 | John Hartmann, CEO and Director |
INVESTMENT HIGHLIGHTS
F O C U S : A C H I E V E S C A L E I N S E L E C T L I M I T E D L I C E N S E M A R K E T S
K E Y F L A G S H I P L O C A T I O N S W I T H H I G H B A R R I E R S T O E N T R Y
D I S C I P L I N E D C A P I T A L A L L O C A T I O N ; S U C C E S S F U L E X E C U T I O N O F M & A
M A N A G E M E N T T E A M W I T H P R O V E N T R A C K R E C O R D O F E X E C U T I O N A N D D I V E R S E S K I L L - S E T
S T R O N G F I N A N C I A L S A N D R E V E N U E G R O W T H
The information contained in this presentation has been prepared by Ascend Wellness Holdings Inc. ("AWH" or the "Company") and contains information pertaining to the business, operations and assets of AWH and its subsidiaries. The information contained in this presentation (a) is provided as at the date hereof and is subject to change without notice, (b) does not purport to contain all the information that may be necessary or desirable to fully and accurately evaluate an investment in the Company, and (c) is not to be considered as a recommendation by AWH that any person make an investment in the Company. The Company is not liable for the accuracy and completeness of the information provided in this presentation. Liability claims against the Company relating to damage of any kind caused by the use or non-use of the information provided or by the use of incorrect or incomplete information are excluded, unless there is evidence of willful intent or gross negligence on the part of the Company.
This publication includes forward looking statements. Please see forward looking statement disclaimer as part of our latest earnings release on our website or inquire with ir@awholdings.com
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Ascend Wellness Holdings Inc. published this content on 08 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 August 2023 22:25:02 UTC.